Sign In
Buy BYSI
$1.15
+0.0200 (+1.77%)
At Close: Jul 31, 2026
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
04:30pm, Monday, 18'th Dec 2023
NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreak
NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreak
SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors
07:45am, Monday, 23'rd Oct 2023
Former Eisai Board Member, Former World Bank General Counsel, and Lecturer at Harvard and Yale Law Schools, Brings Five Decades of Experience in Global Health, Law, Governance, and International Busin
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
03:55pm, Wednesday, 04'th Oct 2023
NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreak
BeyondSpring and Leading Cancer Center to Present Poster at SITC's 38th Annual Meeting
10:00am, Wednesday, 27'th Sep 2023
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbrea
BeyondSpring to Participate in the R.W. Baird's 2023 Global Healthcare Conference
08:00am, Thursday, 07'th Sep 2023
NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbrea
BeyondSpring and Leading Cancer Center to Present Poster at 2023 ASCO Annual Meeting
08:30am, Thursday, 18'th May 2023
NEW YORK, May 18, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaki
Penny Stocks To Buy? 4 To Watch Before Next Week
01:40pm, Thursday, 15'th Dec 2022
Hot penny stocks to watch this week. The post Penny Stocks To Buy?
BeyondSpring, Inc. (BYSI) Q4 2021 Earnings Call Transcript
05:30pm, Thursday, 14'th Apr 2022 The Motley Fool
BYSI earnings call for the period ending March 31, 2022.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Pfizer-BioNTech's COVID-19 Vaccine Booster Shows High Immune Response In Kids Ages 5-11
Pfizer Inc (
BeyondSpring Inc. (BYSI) CEO Lan Huang on Q4 2021 Results - Earnings Call Transcript
01:06pm, Thursday, 14'th Apr 2022
BeyondSpring Inc. (NASDAQ:BYSI ) Q4 2022 Earnings Conference Call April 14, 2022 8:00 AM ET Company Participants Ashley Sierchio - LifeSci Advisors Lan Huang - Co-Founder, Chairman and CEO Ramon Mohan
BeyondSpring Files 2021 Annual Report on Form 20-F
01:04pm, Thursday, 14'th Apr 2022 GlobeNewswire Inc.
NEW YORK, April 14, 2022 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a clinical stage global biopharmaceutical company focused on developing innov
BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
11:00am, Thursday, 14'th Apr 2022 GlobeNewswire Inc.
- Company to host call today, April 14, 2022 at 8:00 am ET
BeyondSpring to Announce Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call on Thursday, April 14, 2022
12:00pm, Friday, 08'th Apr 2022 GlobeNewswire Inc.
NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative c
NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative can
